Evidence map›Paper›PMID 19773443›Full record

ArticleCancer research2009

Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

James C Garbe, Sanchita Bhattacharya, Batul Merchant, Ekaterina Bassett, Karen Swisshelm, Heidi S Feiler, Andrew J Wyrobek, Martha R Stampfer

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Breast-Specific Molecular Clocks Comprised ofCancer prevention research (Philadelphia, Pa.) · 2021
    Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

James C GarbeLife Sciences Divisions, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
Sanchita Bhattacharya
Batul Merchant
Ekaterina Bassett
Karen Swisshelm
Heidi S Feiler
Andrew J Wyrobek
Martha R Stampfer
Lawrence Berkeley National Laboratory · USGeron (United States) · USUniversity of Colorado Health · US

Funding

Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI GRAY, JOE W. · 2004 to 2014
$27.1M
Receptor Tyrosine Kinase/PTEN Interactions in GliomasR01NS045209 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ABOUNADER, ROGER · 2003 to 2017
$4.1M
HUMAN MAMMARY CELLSR01CA024844 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI STAMPFER, MARTHA R · 1985 to 2002
$1.6M
TRF2 Overexpression during Human Breast CarcinogenesisF32CA108480 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BASSETT, EKATERINA · 2004 to 2006
$133k
NCI NIH HHS F32 CA108480NCI NIH HHS R01 CA024844NCI NIH HHS U54 CA112970NINDS NIH HHS R01 NS045209
6 · The paper itself

Abstract

Normal human epithelial cells in culture have generally shown a limited proliferative potential of approximately 10 to 40 population doublings before encountering a stress-associated senescence barrier (stasis) associated with elevated levels of cyclin-dependent kinase inhibitors p16 and/or p21. We now show that simple changes in medium composition can expand the proliferative potential of human mammary epithelial cells (HMEC) initiated as primary cultures to 50 to 60 population doublings followed by p16-positive, senescence-associated beta-galactosidase-positive stasis. We compared the properties of growing and senescent pre-stasis HMEC with growing and senescent post-selection HMEC, that is, cells grown in a serum-free medium that overcame stasis via silencing of p16 expression and that display senescence associated with telomere dysfunction. Cultured pre-stasis populations contained cells expressing markers associated with luminal and myoepithelial HMEC lineages in vivo in contrast to the basal-like phenotype of the post-selection HMEC. Gene transcript and protein expression, DNA damage-associated markers, mean telomere restriction fragment length, and genomic stability differed significantly between HMEC populations at the stasis versus telomere dysfunction senescence barriers. Senescent isogenic fibroblasts showed greater similarity to HMEC at stasis than at telomere dysfunction, although their gene transcript profile was distinct from HMEC at both senescence barriers. These studies support our model of the senescence barriers encountered by cultured HMEC in which the first barrier, stasis, is retinoblastoma-mediated and independent of telomere length, whereas a second barrier (agonescence or crisis) results from telomere attrition leading to telomere dysfunction. Additionally, the ability to maintain long-term growth of genomically stable multilineage pre-stasis HMEC populations can greatly enhance experimentation with normal HMEC.

Indexed as

AdolescentAdultCell Growth ProcessesCells, CulturedCulture MediaDNA DamageEpithelial CellsFemaleFibroblastsGene ExpressionHumansMammary Glands, HumanOxytocinProtein BiosynthesisTelomereTranscription, GeneticCulture MediaOxytocin

Identifiers

PMID19773443
PMCPMC2782785
OpenAlexW2145802624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.